Here’s how we can fix the chronic principal investigator shortage
A fundamental shift by stakeholders is required to address the root cause of this problem in many different aspects of the logistics of running clinical trials
Is clinical trial design complexity behind the high turnover rate for principal investigators?
High principal investigator turnover seems to be primarily centered around the fact that it has become a very demanding job without adequate compensation, financial or otherwise.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
To improve drug development, it’s time to rethink clinical trial site engagement
Patient centricity starts and ends with the investigative site, but better site engagement is needed as the clinical research landscape continues to grow in complexity.